AE Sponsors
Finances
2009
In 2009, Alzheimer Europe gratefully acknowledges the support it has received from its various sponsors.
| Name | Support |
| Association Luxembourg Alzheimer | For the secondment of the Executive Director of Alzheimer Europe and for providing the office space to the organisation free of charge |
| Brussels Airlines | For supporting the AE Conference in Brussels with a special discount for conference participants |
| Bundesministerium für Gesundheit | For their support of the implementation costs of the European Dementia Ethics Network |
| Elan | For their support as bronze sponsors of Alzheimer Europe |
| Fondation Médéric Alzheimer | For their support as silver sponsors of the AE Conference in Brussels and the |
| GlaxoSmithKline | For their support as gold sponsors of Alzheimer Europe |
| Janssen-Cilag | For their support as gold sponsors of Alzheimer Europe and silver sponsors of the AE Conference in Brussels |
| Lundbeck | For their support of silver sponsors of Alzheimer Europe |
| Mazars | For providing the audit of the organisation’s financial accounts free of charge |
| Multimount | For their support as silver sponsors of the AE Conference in Brussels |
| Mutualités libres – Onafhankelijke Ziekenfondsen | For their support as bronze sponsors of the AE Conference in Brussels |
| Novartis | For their support as gold sponsors of Alzheimer Europe |
| Pfizer | For their support as gold sponsors of Alzheimer Europe and silver sponsors of the AE Conference in Brussels |
| Wyeth | For their support as silver sponsors of Alzheimer Europe and bronze sponsors of the AE Conference in Brussels |
2008
Support from organisations and foundations
Alzheimer Europe is grateful to Association Luxembourg Alzheimer and the Luxembourg Ministry for Family for the secondment of the Executive Director of Alzheimer Europe and the office space they make available to the organisation free of charge.
Alzheimer Europe gratefully acknowledges the generous contribution of Fondation Médéric Alzheimer to the EuroCoDe project and the support of Mazars who carried out the audit of the organisation’s financial accounts free of charge.
Support from corporate sponsors
In 2008, Alzheimer Europe had an audited income of €949,008. Sponsorship by the pharmaceutical industry and other corporate sponsors amounted to €248,692 or 26.21%.
The following table lists sponsorship and donations received by individual companies, as well as other payments, such as speakers’ fees, honoraria and support for travel and subsistence costs. The global support received from individual companies is also presented in terms of percentages of the overall income of the organisation in line with the policy of the European Medicines Agency on transparency requirements for accredited patients’ organisations.
| Company | Sponsorship and donations | Honoraria and travel support | TOTAL (2007) | % of AE income (2007) |
| Pfizer | 40,000€ | 486€ | 40,486€ | 4.26% |
| Janssen-Cilag | 40,000€ | 40,000€ | 4.21% |
|
| GlaxoSmithKline | 40,000€ | 40,000€ | 4.21% |
|
| Novartis | 40,000€ | 40,000€ | 4.21% |
|
| Lundbeck | 20,000€ | 9,843€ | 29,843€ | 3.14% |
| Wyeth | 20,000€ | 3,269 | 23,269€ | 2.45% |
| Lilly | 20,000€ | 20,000€ | 2.11% |
|
| Merck Sharp & Dohme | 10,000€ | 10,000€ | 1.05% |
|
| EFPIA | 404€ | 404€ | 0.04% |
|
| Sub-total: Support by the pharmaceutical industry | 244,002€ | 25.71% |
||
| GE Healthcare | 3,190€ | 3,190€ | 3,190€ | 0.34% |
| Innovaacom | 1,500€ | 1,500€ | 0.16% |
|
| Sub-total: Support by other corporate sponsors | 4.690€ | 0.49% |
||
| Total: Support by corporate sponsors | 248,692€ | 26.21% |
||
Last Updated: Monday 12 October 2009
